Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A RUSH ENTERPRISES INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Immatics N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Targa Resources Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A GIBRALTAR INDUSTRIES, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Kymera Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Excelerate Energy, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Voya Financial, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A HOPE BANCORP INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A ASSURED GUARANTY LTD Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A LEVI STRAUSS & CO Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G PPG INDUSTRIES INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Disc Medicine, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Orange County Bancorp, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A DXP ENTERPRISES INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A RAYMOND JAMES FINANCIAL Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G GLAUKOS Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Revolution Medicines, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Surgery Partners, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Dime Community Bancshare Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A DICK'S SPORTING GOODS, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Bancorp, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Hyatt Hotels Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Sitio Royalties Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Tradeweb Markets Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A AMERICAN VANGUARD CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Knight-Swift Transportat Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Akero Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Acadia Healthcare Compan Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Repay Holdings Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A BANNER CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A US Foods Holding Corp. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A HERITAGE COMMERCE CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A QIAGEN N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Edwards Lifesciences Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A STEVEN MADDEN, LTD. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Ameresco, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MYRIAD GENETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G LendingClub Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Denali Therapeutics Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A GULFPORT ENERGY CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A GLOBE LIFE INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G AtriCure, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Sprout Social, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
BBOT begins trading on Nasdaq after $382M SPAC merger completion
-
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition
-
ICG plc: Notification of Major Holdings
-
HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

